Showing 1 to 1 of 1 results
Researchers at CityU have identified and demonstrated for the first time a therapeutic small molecule, M1, that can restore the visual function in the mammalian central nervous system, offering hope for patients with optic nerve damage such as glaucoma-related vision loss.